Tomohiro Watanabe
Scientist Ajinomoto Bio-Pharma Services
Seminars
Wednesday 28th October 2026
Enabling Next-Generation Targeted Protein Degradation through AJICAP® Site-Specific Conjugation and Linker Technologies
1:00 pm
- AJICAP® Conjugation: A site-specific chemical conjugation technology with broad capability for generating precisely defined antibody conjugates
- AJICAP® Linker: A versatile linker technology platform for stable conjugate design, with extended applicability to PROTACs
- PROTAC Applications: Physicochemical and in vitro biological evaluation of DACs enabled by AJICAP® conjugation and linker technologies
